Abstract: Techniques for motion mitigation for uplink power control are disclosed. In one embodiment, a method for use in a satellite communication system comprises: generating a power margin associated with motion of an antenna of a satellite terminal; and generating a first power limit representing a maximum transmit power for the antenna based, at least in part, on the power margin.

Abstract: Techniques for motion mitigation for uplink power control are disclosed. In one embodiment, a method for use in a satellite communication system comprises: generating a power margin associated with motion of an antenna of a satellite terminal; and generating a first power limit representing a maximum transmit power for the antenna based, at least in part, on the power margin.

Abstract: Compositions herein increased creatine retention and/or glycogen storage in muscle. A composition comprises creatine or its derivative and a carbohydrate or its derivative. The carbohydrate is in an amount by weight which is greater than the amount of creatine. The amount of carbohydrate and the amount of creatine are effective for increasing creatine retention and/or glycogen storage in muscle. The compositions may be in the form of a pharmaceutical or a dietary supplement and are intended for use in the human or animal body. Other compositions comprise creatine or an active derivative together with insulin or an active derivative. The amount of creatine and the amount of insulin are effective for increasing creatine retention and/or glycogen storage in muscle. The compositions including creatine and insulin may further contain a carbohydrate or its derivative.

Abstract: The invention relates generally to a method of increasing creatine supply depot of mammals having no disorders in the creatine metabolism, viz. Healthy, thereby increasing muscular strength, shortening the period of re-establishment of phosphorous compounds in energy after work and increasing the body of the muscles. This is achieved by the administration of creatine to the mammals in an amount of at least 15 grams, or 0.2-0.4 g/kg body weight or preferably about 0.3 g/kg body weight, per day for at least 2 days. The invention describes the use of creatine for the manufacturing of a preparation to increase the muscle performance ability in an amount which supplies a daily dose as stated above and a method.